BKD (Brookdale Senior Living) Research & Development: $0 Mil (TTM As of Mar. 2026)


BKD Brookdale Senior Living Inc BKD
43 GF Score
Price $14.69
GF Value $6.32
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Brookdale Senior Living Research & Development?

Brookdale Senior Living BKD +6.14% 43 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates BKD with a GF Score™ of 43/100 and a GF Value™ of $6.32 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Brookdale Senior Living's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Brookdale Senior Living  (NYSE:BKD) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Brookdale Senior Living Research & Development Related Terms

Brookdale Senior Living Research & Development Historical Data

* Premium members only.

The historical data trend for Brookdale Senior Living's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brookdale Senior Living Research & Development Chart

Brookdale Senior Living Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Brookdale Senior Living Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BKD
43GF Score
Brookdale Senior Living Inc BKD
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brookdale Senior Living Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Brookdale Senior Living (BKD) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Brookdale Senior Living and its competitors.
Is Brookdale Senior Living's Research & Development too high?
Brookdale Senior Living's current Research & Development is $0 Mil. Overall, Brookdale Senior Living has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Brookdale Senior Living's Research & Development compare to CON and LFST?
Brookdale Senior Living's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Brookdale Senior Living and its competitors. Brookdale Senior Living's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brookdale Senior Living stock overvalued right now?
Based on GuruFocus' analysis, Brookdale Senior Living (BKD) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.32, compared to a current price of $14.69 — trading 132.4% above its estimated fair value. The current Research & Development is $0 Mil. Brookdale Senior Living's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Brookdale Senior Living (BKD), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Brookdale Senior Living (BKD) Overvalued in 2026?

Based on GuruFocus' analysis, Brookdale Senior Living stock appears to be overvalued. The current stock price of $14.69 is trading 132.4% above its estimated GF Value™ of $6.32. GuruFocus considers Brookdale Senior Living to be Significantly Overvalued.

Key valuation signals for BKD:

  • Research & Development: $0 Mil
  • GF Value™: $6.32 vs. price of $14.69 (132.4% above fair value)
  • GF Score™: 43/100 with 7 warning signs

No single metric tells the full story. See the BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Brookdale Senior Living Business Description

Other Exchanges B7S:Germany
Address 105 Westwood Place, Suite 400, Brentwood, TN, USA, 37027
Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRs). The majority of the revenue is generated from the Assisted Living and Memory Care segment, which offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees, which it receives in exchange for the services provided, and in the form of management fees from certain communities under contract in exchange for the management services provided.
43GF Score

Get the complete analysis for BKD

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.69
Price
$6.32
GF Value